Medical White Papers

RSS

Medical White Papers are in-depth articles aimed to educate and inform site visitors interested in medical research. Some of these papers are derived from sources where we have existing commercial relationships. Such articles are clearly labelled as sponsored content and are only accepted when the content is deemed to add value to the core editorial ethos of News Medical.

Advancing drug safety: Using human liver microphysiological systems to understand liver toxicity

This article talks about how human liver microphysiological systems could be used for research on liver toxicity and drug-induced liver injury (DILI)

From CN-Bio 26 Feb 2024

Alzheimer's disease (AD): Tackling neuroinflammation for early intervention and enhanced treatments

This article talks about neuroinflammation being a crucial aspect of Alzheimer's disease (AD). It explores various targets such as microglia, amyloid and tau, to develop more effective treatments and the importance of early intervention.

From Charles Rivers Laboratories Neuroscience 22 Feb 2024

Psychedelic treatments: Transforming mental health and neurodegenerative disease research

This article talks about how psychedelic treatments have been used to advance research on mental health and neurodegenerative diseases.

From Charles Rivers Laboratories Neuroscience 22 Feb 2024

Exploring chronic pain: TRP ion channels as promising targets for safer and more effective pain management treatments

This article talks about the promising role of targeting TRP Ion Channels for more efficient pain management and how this can be an improvement from current opioid-based treatments.

From Charles Rivers Laboratories Neuroscience 22 Feb 2024

Enhancing motor function assessment: The precision of fine motor kinematic analysis in pharmacological studies

This article talks about the advantages of using fine motor kinematics analysis for motor function assessments over other methods like traditional motor assays.

From Charles Rivers Laboratories Neuroscience 22 Feb 2024

What are the US and EU compliance requirements for GMP ancillary materials in CGT manufacturing?

This article explores the US and EU compliance requirements to ensure patient safety for GMP ancillary materials in cell and gene therapy (CGT) manufacturing.

From ACROBiosystems 22 Feb 2024

A Deep Dive into Immuno-Oncology: Unraveling Cancer Types and Confronting Challenges

This article will uncover the rich history, various cancer types, and hurdles encountered in the ever-evolving field of Immuno-Oncology.

From Sino Biological Inc. 20 Feb 2024

Insights into influenza vaccine types and manufacturing process

In this article, you will gain insights into the various Influenza vaccine types and the manufacturing processes that underlie them.

From Sino Biological Inc. 20 Feb 2024

Novel ASO screening study paves the way for duchenne muscular dystrophy (DMD) therapy advancements

This article talks about the identification of a novel ASO (AON-C19) which opens a promising new avenue for Duchenne Muscular Dystrophy (DMD) therapy development.

From Charles Rivers Laboratories Neuroscience 20 Feb 2024

Cell and gene therapy (CGT) and global supply chain security

The biopharmaceutical industry is constantly changing, and cell and gene therapy (CGT) stands out as an exciting and fast-growing area in the field of medicine. Leading the way in these innovations are autologous and allogeneic cell therapies.

From ACROBiosystems 12 Feb 2024

Deciphering the EMA's regulatory framework: Key insights for US pharmaceutical companies

This article talks about how companies in the US can navigate the EMA's regulatory framework in order to expand and develop new pharmaceutical products.